Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions
Effects of Obefazimod on other drugs
6 evidence topics · 6 sources
Caffeine, a CYP1A2 substrate: caffeine exposure with single and repeated obefazimod doses (Part A)
| Parameter | Day 1, caffeine 50 mg alone | Day 4, caffeine with obefazimod 50 mg | Day 17, caffeine with obefazimod after 14 days of daily dosing |
|---|---|---|---|
| Participants analyzed | “22” | “22” | “22” |
| Caffeine Cmax, ng/mL, mean (SD) | “931(285)” | “930(278)” | “564(242)” |
| Caffeine AUC, h*ng/mL, mean (SD) | “7420(4760)” | “5460(2740)” | “1560(719)” |